Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jul;58(7):959-961.
doi: 10.1007/s00592-021-01702-0. Epub 2021 Mar 15.

Impact of lockdown during COVID-19 emergency on glucose metrics of children and adolescents with type 1 diabetes in Piedmont, Italy

Davide Tinti, Silvia Savastio  1 , Caterina Grosso  2 , Valeria De Donno  3 , Michela Trada, Martina Nugnes  1 , Enrica Bertelli  2 , Luisa Franceschi  3 , Martina Marchisio  4 , Erica Pozzi  1 , Eleonora Tappi  3 , Enrico Felici  2 , Luisa De Sanctis  4 , Ivana Rabbone  5
Affiliations

Impact of lockdown during COVID-19 emergency on glucose metrics of children and adolescents with type 1 diabetes in Piedmont, Italy

Davide Tinti et al. Acta Diabetol. 2021 Jul.
No abstract available

Keywords: Adolescents; COVID-19; Children; Glycemic control; Time in range; Type 1 diabetes.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no conflict of interest.

Figures

Fig. 1
Fig. 1
Plots of time spent in  range (TIR), above range (TAR) and coefficient of variation (CV) before (in white) and during lockdown (in grey)
See this image and copyright information in PMC

References

    1. Singh AK, Gupta R, Ghosh A, Misra A. Diabetes in COVID-19: Prevalence, pathophysiology, prognosis and practical considerations. Diabetes metabolic syndrome. 2020;14(4):303–310. doi: 10.1016/j.dsx.2020.04.004. - DOI - PMC - PubMed
    1. Pitocco D, Tartaglione L, Viti L, et al. Lack of type 1 diabetes involvement in SARS-COV-2 population: Only a particular coincidence? Diabetes Res Clin Pract. 2020;164:108220. doi: 10.1016/j.diabres.2020.108220. - DOI - PMC - PubMed
    1. Cherubini V, Bonfanti R, Casertano A, et al. Time in range in children with type 1 diabetes using treatment strategies based on nonautomated insulin delivery systems in the real world. Diabetes Technol Ther. 2020 doi: 10.1089/dia.2020.0031. - DOI - PubMed
    1. Brener A, Mazor-Aronovitch K, Rachmiel M, et al. Lessons learned from the continuous glucose monitoring metrics in pediatric patients with type 1 diabetes under COVID-19 lockdown. Acta Diabetol. 2020;57(12):1511–1517. doi: 10.1007/s00592-020-01596-4. - DOI - PMC - PubMed
    1. Schiaffini R, Barbetti F, Rapini N, et al. School and pre-school children with type 1 diabetes during Covid-19 quarantine: The synergic effect of parental care and technology. Diabetes Res Clin Pract. 2020;166:108302. doi: 10.1016/j.diabres.2020.108302. - DOI - PMC - PubMed

LinkOut - more resources